Ultrasound Elastography in Imaging Patients With Thyroid Nodules
Elastography in Thyroid Nodule Evaluation
3 other identifiers
interventional
55
1 country
1
Brief Summary
This clinical trial studies how well ultrasound elastography works in assessing the cancer status of potentially malignant thyroid nodules.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 24, 2014
CompletedFirst Submitted
Initial submission to the registry
May 18, 2017
CompletedFirst Posted
Study publicly available on registry
June 5, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 13, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 13, 2019
CompletedResults Posted
Study results publicly available
July 8, 2021
CompletedJuly 8, 2021
June 1, 2021
4.1 years
May 18, 2017
May 18, 2021
June 16, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Stiffness of Thyroid Nodules as Measured by Elastography
Potentially cancerous thyroid nodules will be assessed elastographically, and cancer status will be determined from a fine needle aspiration biopsy results or the surgically excised nodule. The outcome will be reported as median tissue stiffness with standard deviation for nodules that were determined non-cancerous (benign), cancerous, or indeterminate.
1 week
Study Arms (1)
Tissue Stiffness by Elastography
EXPERIMENTALPotentially cancerous thyroid nodules were assessed by elastrography, then a fine needle biopsy specimen or the surgically-excised nodule was assessed pathologically to determine cancer status.
Interventions
Eligibility Criteria
You may qualify if:
- Presence of a thyroid nodule that is amenable to ultrasound guided fine needle aspiration
You may not qualify if:
- Patients who are unable to lie supine for a biopsy
- Pregnant patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University, School of Medicine
Palo Alto, California, 94304, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Aya Kamaya, Professor of Radiology
- Organization
- Stanford University Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Aya Kamaya
Stanford Cancer Institute
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Radiology
Study Record Dates
First Submitted
May 18, 2017
First Posted
June 5, 2017
Study Start
January 24, 2014
Primary Completion
February 13, 2018
Study Completion
February 13, 2019
Last Updated
July 8, 2021
Results First Posted
July 8, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share